Aerie Pharmaceuticals Earning Date (AERI)

USA |NASDAQ |USD

AERI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 2, 2022 Jun 2022 $-0.57 $-0.66 $-0.67
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 2, 2022 Jun 2022 $32.62M $29.84M $27.18M

Aerie Pharmaceuticals's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.

AERI Earnings Date & History Chart

AERI Earnings & Revenue Forecast

AERI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 10 $-0.57 $-0.72 $-0.44
Sep 2022 10 $-0.52 $-0.70 $-0.42
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $-2.13 $-2.74 $-1.61
Dec 2023 8 $-1.28 $-1.81 $-0.54

AERI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 4 / 3 $-0.62 $-0.62 $-0.66
Sep 2022 5 / 2 $-0.60 $-0.60 $-0.61
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 7 / 1 $-2.34 $-2.34 $-2.20
Dec 2023 5 / 2 $-1.37 $-1.37 $-1.21

AERI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 9 $32.62M $30.50M $33.80M
Sep 2022 9 $35.56M $33.89M $37.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $137.03M $132.31M $142.60M
Dec 2023 9 $180.16M $155.30M $200.10M

AERI Earnings Date & Revenue History

AERI Earnings History

|
Show More
Show More

AERI Revenue History

|
Show More
Show More

Aerie Pharmaceuticals Next Earnings Date & Report

AERI Next Earnings Date & Report Preview: Jun 2022 (FQ)

AERI's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.

According to 10 analysts, the average EPS estimation for Aerie Pharmaceuticals's next quarterly earnings is $-0.57, with a low EPS estimation of $-0.72, and a high estimation of $-0.44.

Over the last 1 month, EPS estimates have seen 4 upward revisions and 3 downward. The EPS 1 month trend is $-0.62, the last 2 month trend is $-0.62, and the 3 month trend is $-0.66.

Based on 8 analysts, the average revenue estimation is $32.62M, with a low revenue estimation of $30.50M, and a high estimation of $33.80M.

Aerie Pharmaceuticals Previous Earnings Dates & Reports

AERI Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aerie Pharmaceuticals's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.

AERI's earnings per share (EPS) was $-0.66, missing the consensus analysts forecast of $-0.65 by -1.54%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by -160.55%, and higher than the same period a year before (Mar 2021) by -8.33%.

Revenues were $29.84M, worse than the forecast of $29.90M by -0.22%, down by -73.98% from the previous quarter , and up by 29.89% from the same period last year.

The company reported a net income of $-35.89M.

Free cash flow for the quarter was $60.31M , compared to $-30.86M last quarter and $-30.83M a year before.

AERI ended the quarter with $337.18M in total debt, an increase of 29.36% compared to the previous quarter, and an increase of 46.56% compared to the same quarter a year before.

AERI Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aerie Pharmaceuticals's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

AERI's earnings per share (EPS) was $-1.02, beating the consensus analysts forecast of $-2.79 by -63.44% , and higher than the previous year's EPS (Dec 2020) by -67.25%.

Revenues were $194.13M, better than the forecast of $111.08M by 74.77%, and up by 133.51% from previous year's revenue.

The company reported a net income of $-74.81M.

Aerie Pharmaceuticals reported a free cash flow of $-102.44M for its fiscal year, compared to $-67.79M a year ago.

The company ended the fiscal year with $260.64M in total debt, an increase of 21.06% compared to the previous year.